| Operations and Assets for Operating Segments and Geographic Information |
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
|
|
|
|
|
|
|
|
|
|
For the three months ended March 31, |
(In thousands) |
2020 |
|
2019 |
Revenue from services: |
|
|
|
Pharmaceutical |
$ |
— |
|
|
$ |
— |
|
Diagnostics |
170,839 |
|
|
178,891 |
|
Corporate |
— |
|
|
— |
|
|
$ |
170,839 |
|
|
$ |
178,891 |
|
Revenue from products: |
|
|
|
Pharmaceutical |
$ |
31,074 |
|
|
$ |
25,301 |
|
Diagnostics |
— |
|
|
— |
|
Corporate |
— |
|
|
— |
|
|
$ |
31,074 |
|
|
$ |
25,301 |
|
Revenue from transfer of intellectual property and other: |
|
|
|
Pharmaceutical |
$ |
9,553 |
|
|
$ |
18,259 |
|
Diagnostics |
— |
|
|
— |
|
Corporate |
— |
|
|
— |
|
|
$ |
9,553 |
|
|
$ |
18,259 |
|
Operating loss: |
|
|
|
Pharmaceutical |
$ |
(14,126 |
) |
|
$ |
(29,477 |
) |
Diagnostics |
(18,133 |
) |
|
(33,569 |
) |
Corporate |
(8,503 |
) |
|
(12,272 |
) |
|
$ |
(40,762 |
) |
|
$ |
(75,318 |
) |
Depreciation and amortization: |
|
|
|
Pharmaceutical |
$ |
7,121 |
|
|
$ |
7,526 |
|
Diagnostics |
14,871 |
|
|
16,271 |
|
Corporate |
60 |
|
|
19 |
|
|
$ |
22,052 |
|
|
$ |
23,816 |
|
Loss from investment in investees: |
|
|
|
Pharmaceutical |
$ |
(134 |
) |
|
$ |
(1,854 |
) |
Diagnostics |
— |
|
|
— |
|
Corporate |
— |
|
|
— |
|
|
$ |
(134 |
) |
|
$ |
(1,854 |
) |
Revenues: |
|
|
|
United States |
$ |
180,872 |
|
|
$ |
184,894 |
|
Ireland |
11,901 |
|
|
20,534 |
|
Chile |
10,850 |
|
|
7,865 |
|
Spain |
4,156 |
|
|
4,418 |
|
Israel |
1,707 |
|
|
3,116 |
|
Mexico |
1,841 |
|
|
1,531 |
|
Other |
139 |
|
|
93 |
|
|
$ |
211,466 |
|
|
$ |
222,451 |
|
|
|
|
|
|
|
|
|
|
(In thousands) |
March 31,
2020 |
|
December 31,
2019 |
Assets: |
|
|
|
Pharmaceutical |
$ |
1,157,430 |
|
|
$ |
1,174,639 |
|
Diagnostics |
1,026,880 |
|
|
1,035,112 |
|
Corporate |
48,232 |
|
|
99,521 |
|
|
$ |
2,232,542 |
|
|
$ |
2,309,272 |
|
Goodwill: |
|
|
|
Pharmaceutical |
$ |
234,773 |
|
|
$ |
237,131 |
|
Diagnostics |
434,809 |
|
|
434,809 |
|
Corporate |
— |
|
|
— |
|
|
$ |
669,582 |
|
|
$ |
671,940 |
|
|